3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
72
Breast Neoplasms
9
Neoplasm Metastasis
8
Prostatic Neoplasms, Castration-Resistant
6
Neoplasms
5
Metastatic Castration-resistant Prostate Cancer
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Prostate Cancer Metastatic
3
Metastatic Castration Resistant Prostate Cancer
3
Bulbo-Spinal Atrophy, X-Linked
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Metastatic Hormone Sensitive Prostate Cancer
2
Melanoma
2
mCRPC
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Ureteral Diseases
1
Solid Tumours
1
Small Cell Lung Carcinoma
1
Seizures
1
Salivary Cancer
1
Recurrent Endometrial Endometrioid Adenocarcinoma
1
Pancreatic Neoplasms
1
Non-metastatic, Hormone naïve Prostate Cancer
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms, Squamous Cell
1
Metastatic Progressive Castration-resistant Prostate Cancer
1
Interventions
Doxorubicin
6
pazopanib
5
Trabectedin
4
Radiotherapy
3
temsirolimus
2
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Ifosfamide
2
Dexamethasone
2
sitravatinib
1
selinexor
1
saracatinib
1
romidepsin
1
regorafenib
1
plitidepsin
1
pembrolizumab
1
palbociclib
1
olaratumab
1
milademetan
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
efatutazone
1
cixutumumab
1
brigimadlin
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liposarcoma
×
enzalutamide
×
Clear all
No trials found.